History

Borne by an international shareholder structure, the company was founded on the 9th of April, 2010. It has been set up by Edgar Wingender, the creator of the TRANSFAC® database, and Alexander Kel, a renowned expert in bioinformatic algorithms.

The following is a list of all major achievements, public presentations and other events that have been important for the company's development, in descending order.

2013:
April 11	GeneXplain's CEO, Edgar Wingender, talked in the What Is Life seminar of the SciLifeLab, a collaborative center of Stockholm University, Karolinska Institute, the Royal Institute of Technology (KTH), and Uppsala University. The title of the lecture was "The regulatory code of the genome: mess or message?"
April 10	Edgar Wingender, CEO of geneXplain, delivered the COMPAS-lecture at Karolinska Institute, Stockholm, on the "Construction and analysis of gene regulatory networks".
March 25-26	GeneXplain contributed to the first CASyM Stakeholder Conference on the implementation of Systems Medicine in Europe, held in Lyon, France.
March 20	Alexander Kel, CSO of geneXplain, presented at an Open Session of the SYSCOL project in Oxford, UK.
March 20	Edgar Wingender, CEO of geneXplain, lectures at the VIIth International Congress on "Biotechnology: State of the Art and Prospects of Development" in Moscow about "Construction of gene regulatory networks of cardiomyocyte differentiation".
March 13-15	Alexander Kel, CSO of geneXplain, organizes a track on Gene Regulation at the ISCB Africa ASBCB Conference on Bioinformatics 2013 in Casablanca, Morocco.
March 06	Edgar Wingender, CEO of geneXplain, talks in the colloquium of the Helmholtz Centre for Infection Research (HZI).
February 21	Kick-off meeting to the EU project SysmedIBD in Manchester, UK.
February 01	Release 2.3 of the geneXplain platform!
January 23	Kick-off meeting to the EU project RESOLVE in Lille, France.
2012:
December 02	A new comprehensive classification of human transcription factors has been published and incorporated into the geneXplain platform
December 12-14	Edgar Wingender, CEO of geneXplain, presents at the GIW 2012 in Tainan, Taiwan, on the construction of tissue-specific transcriptional networks.
December 01	GeneXplain is partner of a new EU-funded project, SysmedIBD
November 29-30	Kick-off meeting of the EU-funded MIMOmics research consortium in Leiden, Netherlands.
November 14	Alexander Kel, CSO of geneXplain, is giving a tutorial at the NETTAB Workshop on "Integrated Bio-Search" in Como, Italy.
October 30th	GeneXplain is partner of a new EU-funded project, MIMOmics
October 22-25th	Alexander Kel, in the framework of the Gulbenkian Training Programme in Bioinformatics, held a course on "Hunting for Promoters with NGS data"
October 18-19th	Alexander Kel, CSO of geneXplain, co-organized the PathProt5 forum in Oeiras, Portugal.
October 18th	GeneXplain co-authored an article which has been recommended by the "Faculty of 1000".
September 25th	Release 2.2 of the geneXplain platform issued!
August 21st	The 2012 releases of PASS and PharmaExpert issued!
June 15th	New presentations about IMC and GenomeTraveler and a video about PASS were published.
March	GeneXplain distributor of BIOBASE's TRANSFAC^®, the database on transcription factors, their genomic binding sites and DNA-binding profiles, and TRANSPATH^®, the database on signaling and metabolic pathways, both available under the geneXplain platform!
March 30th	CSO Alexander Kel talked about "From motifs to pathways. How cracking the gene regulatory code can help to find drug targets?" at the workshop FROM GENE TO PHENOTYPE - INTERDISCIPLINARY RESEARCH IN MOLECULAR BIOLOGY AND BIOMEDICINE in Warsaw, Poland, March 28th-30th.
March 23rd	geneXplain became a member of the new European research consortium EpiMetab, funded by the German Federal Ministry of Education and Research.
March 17th	CSO Alexander Kel is main organizer of the workshop "Pathway Analysis in Transcriptomics, Proteomics and Metabolomics" in Orlando, Florida. It is a satellite workshop of the ABRF 2012 "Learning from Biomolecules: The Technology Behind the Story". See also here for further information.
February 9th-10th	CSO Alexander Kel participates in the Proposers Workshop of the Skolkovo Institute of Science and Technology and the MIT in Cambridge, MA.
2011:
December 5th-6th	CSO Alexander Kel attended the 2nd SYSCOL meeting in Geneva.
November 8th-10th	GeneXplain platinum sponsor of the 2011 Joint Conference of CBI & JSBi in Kobe, Japan. Edgar Wingender presented the geneXplain portfolio in three talks: "Efficient large-scale screening of chemical structures for potential biological activities" "The geneXplain platform: from functional genome analysis to biological process simulation" "One out of 24 million: How to computationally identify a new candidate drug against breast cancer"
October 21st-22nd	Alexander Kel was co-organizer and instructor at the International Forum for Pathway Analysis in Proteomics (PathProt-4) organized by the Instituto Gulbenkian de Ciência, Oeiras, Portugal
October 10th	Edgar Wingender gave a presentation pointing "Towards a comprehensive computational platform for next generation drug development – A Russian‐German joint venture" at the German-Russian Forum Biotechnology 2011 in the Convention Center, Hannover, Germany. The workshop was held on the occasion of the Biotechnica exhibition. The slideshow of this presentation is available. http://ht.ly/7wuZF
September 23rd	Alexander Kel talked about "System medicine" at the St. Petersburg Scientific Forum "Science and Society. Physiology and Medicine of the 21st Century".
September 7th	Alexander Kel presented "BioUML - open source integrated platform for collaborative and reproducible research in systems biology" at the COMBINE 2011 in Heidelberg.
August 28th-September 1st	GeneXplain's booth at the 12th International Conference on Systems Biology in Mannheim/Heidelberg, Germany.
August 28th	Alexander Kel gave a presentation about "The SME's role in systems biology approaches to medical applications" at EU workshop on "Collaborative research in Systems Biology: Success stories and research funding opportunities" in Heidelberg.
July 21st-24th	Alexander Kel, CSO of geneXplain, talked about "Modeling of pathway plasticity in cancer" at the Moscow Conference on Computational Molecular Biology (MCCMB'11) in the session of Medical Bioinformatics. He also presented the "geneXplain platform for systems medicine" in a special session on the BioUML/Skolkovo project.
June 27th-30th	Alexander Kel, CSO of geneXplain, gave a course about "Hunting for Genes and Promoters" in the Gulbenkian Training Programme in Bioinformatics, Oeiras, Portugal.
June 10th	Alexander Kel, CSO of geneXplain, participates in the FP7 Health Partnering Event of the European Union in Brussels.
June 9th	Alexander Kel, CSO of geneXplain, presented and discussed about the topic "SMEs in systems biology for medical applications" at Open Information Day on FP7 Health Research of the European Union in Brussels. Get the slides here.
March 23rd	Alexander Kel, CSO of geneXplain, talked about "From analysis of gene regulatory networks to systems medicine" at the VIth Moscow International Congress "Biotechnology: State of the Art and Prospects of Development" in Moscow, Russia.
March 1st	Alexander Kel gives a seminar about "Key-nodes in signal transduction network are potent drug targets for combating survival of tumor cells" at the Argonne National Laboratory, Computation Institute, of the University of Chicago.
February 21st	Alexander Kel, CSO of geneXplain, presented at the ABRF2011 in San Antonio, Texas. In a workshop on the "Identification of Mechanism-Based Biomarkers and Drug Targets Using Pathway Analysis", Alexander has spoken about "GeneXplain — Identification of Causal Biomarkers and Drug Targets in Personalized Cancer Pathways"
February 1st	GeneXplain became partner of the BMBF-supported project GERONTO^SHIELD (Systems biology-driven approach to unravel and revert the mechanisms responsible for poor immune responses in the elderly).
January 26th-28th	GeneXplain sponsors and presents at the Cell Signal-omics conference in Luxembourg.
January 1st	GeneXplain became partner of the EU consortial project SYSCOL (Systems Biology of Colorectal Cancer).

2010:
November 7th-9th	GeneXplain exhibits at the 6th German Conference on Cheminformatics (GCC 2010) in Goslar, Germany.
October	GeneXplain starts distributing PASS and PharmaExpert.
September 20th-22nd	GeneXplain sponsors the 25th German Conference on Bioinformatics (GCB 2010) in Braunschweig, Germany. Alexander Kel (CSO) gives a talk about the geneXplain technology.
July 15th	GeneXplain moves into its new office.
April 9th	GeneXplain is founded by an international partnership.